Study Confirms No Benefit to Taking Metformin for COVID-19 Symptoms
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clinical benefit in taking metformin at a titrated dosage of 1,500 mg pe
DCRI Launches New Podcast to Demystify Clinical Research and Healthcare
The Duke Clinical Research Institute (DCRI) has launched its new podcast, "Beyond the Endpoint," aimed at demystifying clinical research
Cytokinetics Announces Start of COMET-HF, Testing Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure with Severely Reduced Ejection Fraction
Cytokinetics, Incorporated today announced that COMET-HF (Confirmation of O
DCRI Shares Research, Insights, and Expertise during 2024 AHA Scientific Sessions
DCRI’s Schanberg Receives American College of Rheumatology Master Designation
Duke Clinical Research Institute (DCRI) faculty member Laura Schanberg, MD, was rece
DCRI-Led Research Consortium Aims to Reduce Kidney Disease Disparities Tied to Structural Racism
Some 37 million people in the U.S. – more than one in seven adults – have chronic kidney disease (CKD). But not everyone faces the same risk.
Hernandez Honored with QCOR Outstanding Lifetime Achievement Award
All in the Family
Sisters Rebecca Kirkland and Mary Trent Jones are no strangers to volunteering, spending decades serving on boards, with Rebecca on the Duke University Board of Trustees and the D